SecBot SecBot
SC 13G/A ·Filed Nov 10, 2026

SBFM

Sunshine Biopharma Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed11d 14h ago SEC0001213900-26-118164
Passive stake amendment
Actionable Insight • Neutral

The filing is a routine amendment with no change in stake or intent. Monitor for any future conversion to a Schedule 13D, which would signal activist intent, or for any exercise of the warrant that would increase the stake above 9.99%.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$2.75
T+0 close · Nov 10, 2026 · via day close
Latest settled
−12.36%
T+5 · $2.41 · next T+20 in 18d
Vs SPY
−8.47%
α at T+5
Latest observation
−18.10%
T+7 · FF3 residual α
  1. T+0 · Nov 11 $2.75entry
  2. T+1 · 10d ago +3.27%α +3.63% · $2.84
  3. T+5 · 4d ago −12.36%α −8.47% · $2.41
  4. T+7 · todayOpen
  5. T+20 · in 18d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Intracoastal Capital LLC and its principals filed an amended Schedule 13G disclosing a 9.99% passive stake in Sunshine Biopharma, consisting of 430,336 shares issuable upon exercise of a warrant. The stake is unchanged from the prior filing, and the filing certifies no intent to influence control.

Key Financial Metrics

Stake
9.99%
Investor
Intracoastal Capital LLC

Key Facts

  • Intracoastal Capital LLC and its principals Mitchell P. Kopin and Daniel B. Asher filed an amended Schedule 13G.
  • The filing reports beneficial ownership of 430,336 shares of common stock issuable upon exercise of a warrant.
  • The stake represents approximately 9.99% of the outstanding common stock based on 3,877,337 shares outstanding plus the 430,336 warrant shares.
  • The warrant contains a blocker provision preventing exercise above 9.99% beneficial ownership.
  • Without the blocker, the reporting persons would be deemed to beneficially own 4,316,434 shares.
  • The filing certifies the securities were not acquired with the purpose of changing or influencing control of the issuer.
  • This is an amendment to a prior Schedule 13G; the stake percentage is unchanged from the prior filing.

Financial Impact

No change in stake; passive filing with no financial impact.

Risk Factors

  • The blocker provision limits the stake to 9.99%, but the warrant could be exercised if the blocker is removed or modified.
  • The company has a very small market cap ($2M), making it sensitive to large holder actions.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001213900-26-118164
Document: 0001213900-26-118164-index.html0001213900-26-118164
Document: 0001213900-26-118164.txt0001213900-26-118164

Track record

15 reports on SBFM

Performance horizon

7 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +69.19% at T+20 after the Oct 8, 2026 report. 9 of 9 went positive at some point.

Filters
  1. Nov 18, 20263d ago S-1 Bearish 6/10 Entry $2.35 Now $2.23 +5.11% settles Nov 27
  2. Nov 13, 20268d ago DEFA14A Bearish 5/10 Entry $2.60 Now $2.23 +14.23% settles Nov 23
  3. Nov 12, 20269d ago DEF 14A Bearish 5/10 Entry $2.70 to $2.23 Now $2.23 +17.41% ▲ +17.41% +8.85% vs SPY
  4. Nov 10, 202611d ago SC 13G/A Neutral 2/10 Viewing Entry $2.75 to $2.41 Now $2.23 −18.91% ▼ −12.36% −8.47% vs SPY
  5. Oct 14, 20265w ago SC 13G Neutral 3/10 Entry $0.2430 to $0.2154 Now $2.23 +817.70% ▼ −11.36% −11.81% vs SPY
  6. Oct 13, 20265w ago SC 13G Neutral 4/10 Entry $0.2430 to $0.2154 Now $2.23 +817.70% ▼ −11.36% −11.81% vs SPY
  7. Oct 9, 20266w ago 8-K Bearish 6/10 Entry $0.3020 to $0.2418 Now $2.23 −638.41% ▲ +19.93% +18.44% vs SPY
  8. Oct 9, 20266w ago 424B4 Bearish 7/10 Entry $0.3020 to $0.2418 Now $2.23 −638.41% ▲ +19.93% +18.44% vs SPY
  9. Oct 8, 20266w ago EFFECT Bearish 6/10 Entry $8.60 to $4.60 Now $2.23 +74.07% ▲ +46.51% +46.24% vs SPY
  10. Oct 5, 20266w ago SC 13G/A Bearish 5/10 Entry $0.3979 to $0.2363 Now $2.23 −460.44% ▲ +40.61% +40.47% vs SPY
Showing 10 of 15

US Market Status

Market Closed · Opens Mon (25h 23m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 10, 2026